logo-loader
CVE:ACST

Acasti Pharma Inc.

Receive alerts
Market:
CVE
Market Cap:
$201.87 m
Price
$2.38
Change
-0.83%
52 weeks high
3.88
52 weeks low
0.61

In brief

Acasti is a biopharmaceutical innovator focused on the research, development and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. Omega-3 fatty acids have extensive clinical evidence of safety and efficacy in lowering triglycerides in patients with hypertriglyceridemia. Market research commissioned by Acasti suggests there is an important market need for an effective, safe and well-absorbing omega-3 therapeutic with a positive impact on the major lipids associated with cardiovascular disease risk. Since August 2008, Acasti is focused on addressing this important unmet market need.